Michelle R. Healy-Stoffel, Ph.D.
Affiliations: | 2013 | Pharmacology, Toxicology and Therapeutics | University of Kansas, Lawrence, KS, United States |
Area:
NeuropharmacologyGoogle:
"Michelle Healy-Stoffel"Mean distance: 18.84 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Beth Levant | grad student | 2013 | University of Kansas | |
| (Effects of a unilateral intrastriatal 6-hydroxydopamine model of early Parkinson's disease on midbrain dopamine neurons in rats: A stereological study.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Levant B, Healy-Stoffel M. (2018) N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders. Cns & Neurological Disorders Drug Targets |
| Healy-Stoffel M, Omar Ahmad S, Stanford JA, et al. (2014) Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat. Brain Research. 1574: 113-9 |
| Healy-Stoffel M, Ahmad SO, Stanford JA, et al. (2013) Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats. Neuroscience Letters. 546: 26-30 |
| Healy-Stoffel M, Ahmad SO, Stanford JA, et al. (2012) A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study. Journal of Neuroscience Methods. 210: 187-94 |